Annual Shareholders Equity
$8.71 B
-$212.00 M-2.38%
December 1, 2023
Summary
- As of February 8, 2025, SVA annual stockholders equity is $8.71 billion, with the most recent change of -$212.00 million (-2.38%) on December 1, 2023.
- During the last 3 years, SVA annual shareholders equity has risen by +$7.96 billion (+1066.74%).
- SVA annual shareholders equity is now -6.63% below its all-time high of $9.33 billion, reached on December 31, 2021.
Performance
SVA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$8.65 B
-$60.23 M-0.69%
June 1, 2024
Summary
- As of February 8, 2025, SVA quarterly stockholders equity is $8.65 billion, with the most recent change of -$60.23 million (-0.69%) on June 1, 2024.
- Over the past year, SVA quarterly shareholders equity has dropped by -$15.69 million (-0.18%).
- SVA quarterly shareholders equity is now -8.65% below its all-time high of $9.47 billion, reached on June 30, 2022.
Performance
SVA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
SVA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.4% | -0.2% |
| 3 y3 years | +1066.7% | +47.3% |
| 5 y5 years | +3336.6% | +2841.7% |
SVA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.6% | at low | -8.7% | at low |
| 5 y | 5-year | -6.6% | +2862.2% | -8.7% | +2992.5% |
| alltime | all time | -6.6% | >+9999.0% | -8.7% | >+9999.0% |
Sinovac Biotech Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $8.65 B(-0.7%) |
| Dec 2023 | $8.71 B(-2.4%) | $8.71 B(+0.5%) |
| Jun 2023 | - | $8.66 B(-2.9%) |
| Dec 2022 | $8.92 B(-4.4%) | $8.92 B(-5.8%) |
| Jun 2022 | - | $9.47 B(+1.5%) |
| Dec 2021 | $9.33 B(+1149.5%) | $9.33 B(+58.8%) |
| Jun 2021 | - | $5.87 B(+686.8%) |
| Dec 2020 | $746.47 M(+153.9%) | $746.47 M(+143.6%) |
| Sep 2020 | - | $306.39 M(+9.5%) |
| Jun 2020 | - | $279.68 M(-1.4%) |
| Mar 2020 | - | $283.78 M(-3.5%) |
| Dec 2019 | $294.02 M(+16.0%) | $294.02 M(+10.4%) |
| Sep 2019 | - | $266.31 M(-0.1%) |
| Jun 2019 | - | $266.56 M(+2.9%) |
| Mar 2019 | - | $259.10 M(+2.2%) |
| Dec 2018 | $253.43 M(+67.7%) | $253.43 M(+55.1%) |
| Jun 2018 | - | $163.37 M(+8.1%) |
| Dec 2017 | $151.15 M(+30.6%) | $151.15 M(+16.0%) |
| Jun 2017 | - | $130.32 M(+12.6%) |
| Dec 2016 | $115.77 M(-4.8%) | $115.77 M(+0.7%) |
| Sep 2016 | - | $114.97 M(+2.8%) |
| Jun 2016 | - | $111.80 M(-9.4%) |
| Mar 2016 | - | $123.43 M(+1.5%) |
| Dec 2015 | $121.65 M(-3.9%) | $121.65 M(-1.7%) |
| Sep 2015 | - | $123.71 M(-2.9%) |
| Jun 2015 | - | $127.46 M(+2.2%) |
| Mar 2015 | - | $124.75 M(-1.4%) |
| Dec 2014 | $126.56 M(-1.6%) | $126.56 M(+0.6%) |
| Sep 2014 | - | $125.82 M(+0.8%) |
| Jun 2014 | - | $124.81 M(-1.9%) |
| Mar 2014 | - | $127.17 M(-1.2%) |
| Dec 2013 | $128.68 M(+9.3%) | $128.68 M(+5.7%) |
| Sep 2013 | - | $121.73 M(+2.5%) |
| Jun 2013 | - | $118.81 M(+2.3%) |
| Mar 2013 | - | $116.18 M(-1.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $117.72 M(-9.4%) | $117.72 M(-3.6%) |
| Sep 2012 | - | $122.10 M(-1.7%) |
| Jun 2012 | - | $124.17 M(-0.7%) |
| Mar 2012 | - | $125.00 M(-3.8%) |
| Dec 2011 | $129.92 M(+2.8%) | $129.92 M(+3.0%) |
| Sep 2011 | - | $126.16 M(-0.9%) |
| Jun 2011 | - | $127.31 M(+2.1%) |
| Mar 2011 | - | $124.66 M(-1.4%) |
| Dec 2010 | $126.44 M(+78.9%) | $126.44 M(-6.3%) |
| Sep 2010 | - | $134.97 M(+0.8%) |
| Jun 2010 | - | $133.84 M(+1.1%) |
| Mar 2010 | - | $132.33 M(+87.3%) |
| Dec 2009 | $70.66 M(+42.1%) | $70.66 M(+14.9%) |
| Sep 2009 | - | $61.52 M(+11.1%) |
| Jun 2009 | - | $55.36 M(+11.7%) |
| Mar 2009 | - | $49.55 M(-0.3%) |
| Dec 2008 | $49.71 M(+65.7%) | $49.71 M(+3.9%) |
| Sep 2008 | - | $47.85 M(+1.7%) |
| Jun 2008 | - | $47.03 M(+10.2%) |
| Mar 2008 | - | $42.68 M(+42.2%) |
| Dec 2007 | $30.00 M(+55.9%) | $30.00 M(+9.4%) |
| Sep 2007 | - | $27.44 M(+14.8%) |
| Jun 2007 | - | $23.90 M(+24.2%) |
| Dec 2006 | $19.24 M(+6.8%) | $19.24 M(+5.8%) |
| Jun 2006 | - | $18.18 M(+0.9%) |
| Dec 2005 | $18.02 M(+44.9%) | $18.02 M(+18.7%) |
| Jun 2005 | - | $15.18 M(+22.0%) |
| Dec 2004 | $12.44 M(+102.2%) | $12.44 M(+17.2%) |
| Sep 2004 | - | $10.61 M(-1.7%) |
| Jun 2004 | - | $10.79 M(+75.5%) |
| Dec 2003 | $6.15 M(+6086.7%) | $6.15 M |
| Apr 2002 | $99.40 K(-114.6%) | - |
| Apr 2001 | -$683.00 K(+85.4%) | - |
| Apr 2000 | -$368.40 K(-1370.3%) | - |
| Apr 1999 | $29.00 K | - |
FAQ
- What is Sinovac Biotech annual stockholders equity?
- What is the all time high annual shareholders equity for Sinovac Biotech?
- What is Sinovac Biotech annual shareholders equity year-on-year change?
- What is Sinovac Biotech quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Sinovac Biotech?
- What is Sinovac Biotech quarterly shareholders equity year-on-year change?
What is Sinovac Biotech annual stockholders equity?
The current annual shareholders equity of SVA is $8.71 B
What is the all time high annual shareholders equity for Sinovac Biotech?
Sinovac Biotech all-time high annual stockholders equity is $9.33 B
What is Sinovac Biotech annual shareholders equity year-on-year change?
Over the past year, SVA annual stockholders equity has changed by -$212.00 M (-2.38%)
What is Sinovac Biotech quarterly stockholders equity?
The current quarterly shareholders equity of SVA is $8.65 B
What is the all time high quarterly shareholders equity for Sinovac Biotech?
Sinovac Biotech all-time high quarterly stockholders equity is $9.47 B
What is Sinovac Biotech quarterly shareholders equity year-on-year change?
Over the past year, SVA quarterly stockholders equity has changed by -$15.69 M (-0.18%)